• Skip to main content

Mobius Therapeutics

Dedicated to perioperative pharmaceuticals for ophthalmology

  • Home
  • Products
    • Product Lineup
    • Peri-Operative Resource Center
  • Place An Order
  • News
  • About Us
    • Company Profile
    • The Mobius Team
    • Terms of Use
    • Privacy Policy
    • Corporate Responsibility
  • Contact Us

Mobius Product Lineup

Perioperative Pharmaceutical Franchise Dedicated to Ophthalmology

Mobius Therapeutics is dedicated to developing sterile injectable pharmaceuticals optimized for ophthalmic applications. With a deep pipeline of products under development, we at Mobius continue our mission of improving the convenience, safety and integrity of perioperative pharmaceuticals by seeking innovative methods of delivery on our mission to be your one-stop shop for FDA approved peri-operative drugs.

Mitosol


Mitosol, finally a Mitomycin that has it all! The only FDA-approved formulation of ophthalmic MMC.

California Warning Label

Visit Site

Amphadase

Amphadase® 
(hyaluronidase injection, USP)
150 USP units/mL

Using Hylenex® or Vitrase®? SAVE MONEY by switching to Amphadase®. 2-year shelf life & single dose vials, 150 USP units/mL.

Visit Site

Amphadase® is a registered trademark of Amphastar Pharmaceuticals, Inc., Hylenex® is a registered trademark of Halozyme, Inc.
Vitrase® is a registered trademark of ISTA Pharmaceuticals, Inc.

WMT-002 Rev 07/2022

© 2023 · Mobius Therapeutics